Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
作者信息
Kelles A, Herman J, Tjandra-Maga T B, Van Damme-Lombaerts R
机构信息
Pediatric Transplant Unit, University Hospital Leuven, Leuven, Belgium.
出版信息
Transplant Proc. 1998 Aug;30(5):1995-6. doi: 10.1016/s0041-1345(98)00509-0.
PMID:9723366
Abstract
摘要
相似文献
1
Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
Transplant Proc. 1998 Aug;30(5):1995-6. doi: 10.1016/s0041-1345(98)00509-0.
2
Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.稳定的肾移植受者从传统的山地明转换为新山地明治疗。
Transplant Proc. 1996 Aug;28(4):2199-201.
3
Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
Transplant Proc. 1996 Aug;28(4):2165-8.
4
The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.瑞典将接受山地明治疗的移植患者转换为新剂型新山地明的全国性经验。瑞典新山地明转换研究组。
Transplant Proc. 1997 Feb-Mar;29(1-2):280-3. doi: 10.1016/s0041-1345(96)00093-0.
5
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
Transplant Proc. 1998 Dec;30(8):3955-7. doi: 10.1016/s0041-1345(98)01303-7.
6
Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
Transplant Proc. 1998 Aug;30(5):1762-3. doi: 10.1016/s0041-1345(98)00420-5.
7
Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
Transplant Proc. 1997 Feb-Mar;29(1-2):277-9. doi: 10.1016/s0041-1345(96)00092-9.
8
Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients.肾移植受者中，从每日一次的山地明转换为每日两次的新山地明环孢素的安全性和有效性。
Transplant Proc. 1998 Aug;30(5):1746-8. doi: 10.1016/s0041-1345(98)00413-8.
9
Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.从山地明转换为新山地明对稳定肾移植受者肾小球滤过率的影响。
Transplant Proc. 1997 Feb-Mar;29(1-2):298-9. doi: 10.1016/s0041-1345(96)00116-9.
10
Comparative pharmacokinetic study of Neoral vs Sandimmun in Japanese stable renal allograft recipients.新山地明与环孢素在日本稳定肾移植受者中的比较药代动力学研究。
Transplant Proc. 1999 Nov;31(7):3089-92. doi: 10.1016/s0041-1345(99)00782-4.
引用本文的文献
1
A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.他克莫司与微乳化环孢素在儿童肾移植受者中的药代动力学比较。
Eur J Clin Pharmacol. 2004 Aug;60(6):421-6. doi: 10.1007/s00228-004-0773-9. Epub 2004 Jul 1.
2
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.
Zotero 插件